A Phase IV, Multicenter, Randomized, Double-blinded, Clinical Trial to Confirm the Efficacy of the 75 IU Dose of Luveris® vs. Placebo When Administered With Follitropin Alfa for Induction of Follicular Development and Pregnancy in Hypogonadotropic Hypogonadal Women With Profound LH Deficiency, as Defined by a Baseline LH Level <1.2 IU/L

Trial Profile

A Phase IV, Multicenter, Randomized, Double-blinded, Clinical Trial to Confirm the Efficacy of the 75 IU Dose of Luveris® vs. Placebo When Administered With Follitropin Alfa for Induction of Follicular Development and Pregnancy in Hypogonadotropic Hypogonadal Women With Profound LH Deficiency, as Defined by a Baseline LH Level <1.2 IU/L

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 11 Jul 2013

At a glance

  • Drugs Follitropin alfa; Lutropin alfa
  • Indications Female infertility; Hypogonadism
  • Focus Therapeutic Use
  • Sponsors Merck Serono
  • Most Recent Events

    • 13 Jun 2012 Actual patient number 11 added as reported by ClinicalTrials.gov.
    • 13 Jun 2012 Planned end date changed from 1 Dec 2012 to 1 Apr 2012 as reported by ClinicalTrials.gov.
    • 13 Jun 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top